No Data
Optimistic Investors Push Qinghai Spring Medicinal Resources Technology Co., Ltd. (SHSE:600381) Shares Up 30% But Growth Is Lacking
ST Spring: Qinghai Spring 2024 Third Quarter Report
Qinghai Spring 2024 Third Quarter Report
Special treat Spring (600381.SH): Some share repurchases were in violation.
On June 26, 2024, during the closing auction period between 14:57 and 15:00, ST Spring (600381.SH) bought back a total of 0.1 million shares at a fill price of 1.94 yuan/share and a total transaction amount of 0.194 million yuan. It was verified by the company that the buyback operation was due to the lack of experience and operational errors of the buyback personnel, and was not a subjective intentional violation of Article 19(2) of the Shanghai Stock Exchange Listed Company Self-Discipline Supervision Guidelines on Share Repurchases (revised in December 2023).
qinghai spring medicinal resources technology semi-annual report for 2024.
Qinghai Spring Medicinal Resources Technology Summary of the Semi-annual Report in 2024.
Despite Currently Being Unprofitable, Qinghai Spring Medicinal Resources Technology (SHSE:600381) Has Delivered a 39% Return to Shareholders Over 3 Years
